Related Experiment Video
Updated: Jul 9, 2026

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses
Published on: August 31, 2014
Prevalence and impact of HIV-1 protease mutation L76V on lopinavir resistance
Carmen de Mendoza1, Carolina Garrido, Angélica Corral
1Department of Infectious Diseases, Hospital Carlos III, Madrid, Spain.
Abstract:
Besides I47A, mutation L76V at the HIV protease gene has recently been proposed to cause lopinavir resistance. This change was present in 37 (2.7%) out of 1376 patients failing protease inhibitor containing regimens. Although 26 (70%) were on lopinavir, most had previously failed other protease inhibitors and carried multiple protease inhibitor resistance mutations. Therefore, L76V does not appear to be a primary lopinavir resistance change when the drug is used in combination therapy.
Related Concept Videos
Viral Mutations
Retrovirus Life Cycles
Inhibitors of Virion Maturation and Assembly
Antiviral Nucleoside Inhibitors
Single Nucleotide Polymorphisms-SNPs
Retroviruses

